2 May 2008 – Case of the Week #117
To view the images or references, you must click on the links in blue. Links in green are to journals with free full text-no registration.
This email is sent only to subscribers. To subscribe or unsubscribe, email [email protected], indicating subscribe or unsubscribe to Case of the Week. There is no charge. We do not sell, share or use your email address for any other purpose. We also have free email subscriptions for Pathologist/PhD jobs (biweekly), Other laboratory jobs (biweekly), website news (monthly) and new books (monthly). Email us to subscribe.
We recently established The Detroit College Promise. This program, modeled on the Kalamazoo Promise, will provide tuition scholarships for Detroit Public School students. We expect that it will dramatically increase the number of Detroit college graduates over time, and transform the City of Detroit into a center of urban brainpower and economic prosperity. Click on our Home Page button (left side, or click here) for more information. As pathologists, it is important for us to take the lead in charitable activities, not only because they are important, but to publicize our somewhat invisible specialty. Most of the public, or even other physicians, has no idea what we do.
We thank Debra L. Zynger, M.D., Ava Hosseini, B.A. and Ximing J. Yang, M.D., Ph.D., Northwestern Memorial Hospital, Northwestern University, Chicago, Illinois (USA) for contributing this case. To contribute a Case of the Week, email [email protected] with the clinical history, your diagnosis and microscopic images in JPG, GIF or TIFF format (send as attachments, we will shrink if necessary). Please include any other images (gross, immunostains, etc.) that may be helpful or interesting. We will write the discussion (unless you want to), list you as the contributor, and send you $35 (US dollars) for your time after we send out the case. Please only send cases with high quality images and a diagnosis that is somewhat unusual (or a case with unusual features).
Case of the Week #117
A 70 year old man had laparoscopic robotic-assisted radical prostatectomy.
What is your diagnosis?
Pseudohyperplastic variant of prostatic adenocarcinoma
The malignant nature of the hyperplastic appearing glands was confirmed with the triple stain, which showed lack of basal cells (i.e. no staining) by p63 and high molecular weight keratin, and staining of the hyperplastic cells by AMACR: triple stain #1 (AMACR, p63, HMWK); #2. The normal appearing glands served as controls.
Pseudohyperplastic variant of prostatic adenocarcinoma is a rare variant in which at least 60% of the tumor has architectural features resembling benign hyperplastic glands (AJSP 2000;24:1039). The tumor typically has complex, medium to large sized glands with crowding, papillary infoldings and branching or cystic dilatations. The nuclei are enlarged, and often have prominent nucleoli. There are usually pink amorphous secretions, and often crystalloids. At low power, transition to typical, small acinar adenocarcinomas may be a helpful diagnostic clue (AJSP 1998;22:1239). With core needle biopsies, the only diagnostic clue may be a subtle disruption of the normal glandular - stromal relationship. Basal cell stains (p63, HMWK) are important to confirm the absence of basal cells, and the tumor cells are immunoreactive for AMACR / P504S in 70% of cases (AJSP 2003;27:772).
Pseudohyperplastic variant may be misdiagnosed as benign hyperplasia. In one study, the rate of false negative diagnoses was 1.3% for TURP specimens (Pathol Oncol Res 2003;9:232). The differential diagnosis also includes high grade prostatic intraepithelial neoplasia. Although high grade PIN also shows papillary infoldings with prominent nucleoli, the glands are not as crowded or infiltrative.
Nat Pernick, M.D., President
30100 Telegraph Road, Suite 404
Bingham Farms, Michigan (USA) 48025
Email: [email protected]
Alternate email: [email protected]m